Washington, Sept 28 : A new research has revealed that pregnancy does not harm chances of survival from cancer.

The study by Norwegian scientists has found that for almost all types of cancer, the survival of women who are diagnosed during pregnancy or who became pregnant after being treated for the disease is no different from that of other female cancer patients.

Washington, Sept 28 : An experimental drug called pertuzumab may help prolong the survival time for women with recurrent ovarian cancer, a University of Alabama at Birmingham doctor has said.

Dr. Sharmila Makhija, an associate professor in the Division of Gynecologic Oncology at the university, said that Phase II clinical trial data showed that pertuzumab added weeks to the lives of Stage III ovarian cancer patients, whose disease had returned after treatment with the existing chemotherapy regimens.

Washington, September 28 : Gorging on those French fries and hamburgers may not be a good idea anymore, with a new study showing that fatty foods cooked at high temperatures may cause a significant dysfunction in blood vessel dilation that can lead to heart disease.